Opto Circuits (India), a Rs.2,350 crore plus vertically integrated multinational medical technology entity, has suffered setback during the third quarter ended December 2013 on account of lower growth in sales and higher interest burden. Its net profit declined by 9.5 per cent to Rs.113.26 crore from Rs.125.08 crore in the corresponding period of last year. Its net sales improved only by 1.2 per cent to Rs.619 core from Rs.611 crore. EBDITA went down by 2.7 per cent to Rs.162.79 crore from Rs.167.29 crore.

For the nine months period ended December 2012, Opto's net profit improved only by 1.4 per cent to Rs.367.52 crore from Rs.362.53 crore in the similar period of last year. Its net sales moved by 14.6 per cent to Rs.1,941 crore from Rs.1,694 crore. International revenues from healthcare touched to Rs.1,913 crore and its domestic sales amounted to Rs.17.29 crore during first nine months of 2012-12. With higher other operating income and other income, its EBDITA moved up by 11.2 per cent to Rs.517.17 crore from Rs.464.99 crore. Interest burden went up sharply by 38.7 per cent to Rs.57.60 crore from Rs.41.54 crore. Further its depreciation provision surged by 62.7 per cent to Rs.65.07  crore from Rs.40.01 crore.

For the full year ended March 2012, the company posted net sales of Rs.2,357 crore and earned a net profit of Rs.572 crore with annual EPS of Rs.23.60. The company issued bonus share in the ratio of 3:10 and declared equity dividend of 30 per cent.